BinaxNOW COVID-19 Antigen Self Test
GPTKB entity
Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
COVID-19 rapid antigen test
|
gptkbp:ageRange |
2 years and older
|
gptkbp:authority |
gptkb:FDA_Emergency_Use_Authorization
|
gptkbp:countryOfOrigin |
gptkb:United_States
|
gptkbp:detects |
SARS-CoV-2 nucleocapsid protein antigen
|
gptkbp:firstAuthorized |
2020
|
gptkbp:forHomeUse |
true
|
https://www.w3.org/2000/01/rdf-schema#label |
BinaxNOW COVID-19 Antigen Self Test
|
gptkbp:intendedUse |
Detection of SARS-CoV-2 antigen
|
gptkbp:manufacturer |
gptkb:Abbott_Laboratories
|
gptkbp:marketedAs |
gptkb:Abbott_Diagnostics_Scarborough,_Inc.
|
gptkbp:OTC |
true
|
gptkbp:packaging |
2 tests per box
|
gptkbp:prescriptionRequired |
false
|
gptkbp:regulates |
gptkb:Emergency_Use_Authorization_(EUA)
|
gptkbp:result |
15 minutes
|
gptkbp:type |
Lateral flow immunoassay
Nasal swab |
gptkbp:bfsParent |
gptkb:BinaxNOW
|
gptkbp:bfsLayer |
7
|